{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:57:43Z","timestamp":1787803063679,"version":"build-2784847793"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Endoscopic resection for early oesophageal cancer was introduced around 2000 in the Netherlands. The scientific question was how the treatment and survival of early oesophageal and gastro-oesophageal junction cancer has changed over time in the Netherlands.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data were obtained from the nationwide population-based Netherlands Cancer Registry. All patients diagnosed with clinical in situ or T1 oesophageal or GOJ cancer without lymph node or distance metastasis during the study period (2000\u20132014) were extracted. Primary outcome parameters were the trends in treatment modalities over time and relative survival of each treatment regime.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 1020 patients were diagnosed with a clinical in situ or T1 oesophageal or gastro-oesophageal junction cancer without lymph node or distance metastasis. The proportion of patients who received endoscopic treatment increased from 2.5% in 2000 to 58.1% in 2014. During the same period the proportion of patients who received surgery decreased from 57.5 to 23.1%. Five-year relative survival of all patients was 69%. Five-year relative survival after endoscopic therapy was 83% and after surgery 80%. Relative excess risk analyses showed no significant difference in survival between patients in the endoscopic therapy group and patients in the surgery group after adjustment for age, sex, clinical TNM classification, morphology and tumour location (RER 1.15; CI 0.76\u20131.75; <jats:italic>p<\/jats:italic> 0.76).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our results demonstrate an increase in endoscopic treatment and a decrease of surgical treatment for in situ and T1 oesophageal\/GOJ cancer between 2000\u20132014 in the Netherlands. The relative 5-year survival after endoscopic treatment is high (83%) and comparable with surgery (80%).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00464-023-09914-x","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T18:02:52Z","timestamp":1677520972000},"page":"4535-4544","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Endoscopic therapy replaces surgery for clinical T1 oesophageal cancer in the Netherlands: a nationwide population-based study"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4089-0274","authenticated-orcid":false,"given":"Irma C.","family":"Noordzij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marije L.","family":"Hazen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grard A. P.","family":"Nieuwenhuijzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob H. A.","family":"Verhoeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik J.","family":"Schoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"key":"9914_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359\u2013E386. https:\/\/doi.org\/10.1002\/ijc.29210","journal-title":"Int J Cancer"},{"key":"9914_CR2","doi-asserted-by":"publisher","first-page":"17048","DOI":"10.1038\/nrdp.2017.48","volume":"3","author":"EC Smyth","year":"2017","unstructured":"Smyth EC, Lagergren J, Fitzgerald RC, Lordick F, Shah MA, Lagergren P, Cunningham D (2017) Oesophageal cancer. Nat Rev Dis Primers 3:17048. https:\/\/doi.org\/10.1038\/nrdp.2017.48","journal-title":"Nat Rev Dis Primers"},{"key":"9914_CR3","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.ejca.2012.01.009","volume":"48","author":"JL Dikken","year":"2012","unstructured":"Dikken JL, Lemmens VE, Wouters MWJM, Wijnhoven BP, Siersema PD, Nieuwenhuijzen GA, van Sandick JW, Cats A, Verheij M, Coebergh JW, van de Velde CJH (2012) Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands. Eur J Cancer 48:1624\u20131632. https:\/\/doi.org\/10.1016\/j.ejca.2012.01.009","journal-title":"Eur J Cancer"},{"key":"9914_CR4","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1002\/cncr.27834","volume":"119","author":"C Hur","year":"2013","unstructured":"Hur C, Miller M, Kong CY, Dowling EC, Nattinger KJ, Dunn M, Feuer EJ (2013) Trends in esophageal adenocarcinoma incidence and mortality. Cancer 119:1149\u20131158. https:\/\/doi.org\/10.1002\/cncr.27834","journal-title":"Cancer"},{"key":"9914_CR5","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.athoracsur.2007.10.106","volume":"85","author":"A Dubecz","year":"2008","unstructured":"Dubecz A, Schwartz SI (2008) Franz John A. Torek Ann Thorac Surg 85:1497\u20131499. https:\/\/doi.org\/10.1016\/j.athoracsur.2007.10.106","journal-title":"Torek Ann Thorac Surg"},{"key":"9914_CR6","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/BF00316791","volume":"4","author":"H Inoue","year":"1990","unstructured":"Inoue H, Endo M (1990) Endoscopic esophageal mucosal resection using a transparent tube. Surg Endosc 4:198\u2013201. https:\/\/doi.org\/10.1007\/BF00316791","journal-title":"Surg Endosc"},{"key":"9914_CR7","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/j.1572-0241.2008.01835.x","volume":"103","author":"KK Wang","year":"2008","unstructured":"Wang KK, Sampliner RE, Practice Parameters Committee of the American College of Gastroenterology (2008) Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett\u2019s esophagus. Am J Gastroenterol 103:788\u201397. https:\/\/doi.org\/10.1111\/j.1572-0241.2008.01835.x","journal-title":"Am J Gastroenterol"},{"key":"9914_CR8","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/gut.2010.210229","volume":"59","author":"RE Pouw","year":"2010","unstructured":"Pouw RE, Seewald S, Gondrie JJ, Deprez PH, Piessevaux H, Pohl H, R\u00f6sch T, Soehendra N, Bergman JJ (2010) Stepwise radical endoscopic resection for eradication of Barrett\u2019s oesophagus with early neoplasia in a cohort of 169 patients. Gut 59:1169\u20131177. https:\/\/doi.org\/10.1136\/gut.2010.210229","journal-title":"Gut"},{"key":"9914_CR9","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1136\/gut.2007.142539","volume":"57","author":"O Pech","year":"2008","unstructured":"Pech O, Behrens A, May A, Nachbar L, Gossner L, Rabenstein T, Manner H, Guenter E, Huijsmans J, Vieth M, Stolte M, Ell C (2008) Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett\u2019s oesophagus. Gut 57:1200\u20131206. https:\/\/doi.org\/10.1136\/gut.2007.142539","journal-title":"Gut"},{"key":"9914_CR10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.amjsurg.2018.12.058","volume":"218","author":"A Wirsching","year":"2019","unstructured":"Wirsching A, Boshier PR, Krishnamoorthi R, Larsen MC, Irani S, Ross AS, Low DE (2019) Endoscopic therapy and surveillance versus esophagectomy for early esophageal adenocarcinoma: a review of early outcomes and cost analysis. Am J Surg 218:164\u2013169. https:\/\/doi.org\/10.1016\/j.amjsurg.2018.12.058","journal-title":"Am J Surg"},{"key":"9914_CR11","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1097\/JTO.0b013e3182897bf1","volume":"8","author":"MF Berry","year":"2013","unstructured":"Berry MF, Zeyer-Brunner J, Castleberry AW, Martin JT, Gloor B, Pietrobon R, D\u2019Amico TA, Worni M (2013) Treatment modalities for T1N0 esophageal cancers: a comparative analysis of local therapy versus surgical resection. J Thorac Oncol 8:796\u2013802. https:\/\/doi.org\/10.1097\/JTO.0b013e3182897bf1","journal-title":"J Thorac Oncol"},{"key":"9914_CR12","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.gie.2013.08.002","volume":"79","author":"S Wani","year":"2014","unstructured":"Wani S, Drahos J, Cook MB, Rastogi A, Bansal A, Yen R, Sharma P, Das A (2014) Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study. Gastrointest Endosc 79:224-232.e1. https:\/\/doi.org\/10.1016\/j.gie.2013.08.002","journal-title":"Gastrointest Endosc"},{"key":"9914_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju133","author":"RP Merkow","year":"2014","unstructured":"Merkow RP, Bilimoria KY, Keswani RN, Chung J, Sherman KL, Knab LM, Posner MC, Bentrem DJ (2014) Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/dju133","journal-title":"J Natl Cancer Inst"},{"key":"9914_CR14","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1111\/j.1572-0241.2008.01889.x","volume":"103","author":"A Das","year":"2008","unstructured":"Das A, Singh V, Fleischer DE, Sharma VK (2008) A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. Am J Gastroenterol 103:1340\u20131345. https:\/\/doi.org\/10.1111\/j.1572-0241.2008.01889.x","journal-title":"Am J Gastroenterol"},{"key":"9914_CR15","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1053\/j.gastro.2009.05.059","volume":"137","author":"GA Prasad","year":"2009","unstructured":"Prasad GA, Wu TT, Wigle DA, Buttar NS, Wongkeesong L-M, Dunagan KT, Lutzke LS, Borkenhagen LS, Wang KK (2009) Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett\u2019s esophagus. Gastroenterology 137:815\u2013823. https:\/\/doi.org\/10.1053\/j.gastro.2009.05.059","journal-title":"Gastroenterology"},{"key":"9914_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1541-0420.2011.01640.x","volume":"68","author":"MP Perme","year":"2012","unstructured":"Perme MP, Stare J, Est\u00e8ve J (2012) On estimation in relative survival. Biometrics 68:113\u2013120. https:\/\/doi.org\/10.1111\/j.1541-0420.2011.01640.x","journal-title":"Biometrics"},{"key":"9914_CR17","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s11605-017-3563-2","volume":"21","author":"Y Zeng","year":"2017","unstructured":"Zeng Y, Liang W, Liu J, He J (2017) Endoscopic treatment versus esophagectomy for early-stage esophageal cancer: a population-based study using propensity score matching. J Gastrointest Surg 21:1977\u20131983. https:\/\/doi.org\/10.1007\/s11605-017-3563-2","journal-title":"J Gastrointest Surg"},{"key":"9914_CR18","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1136\/gutjnl-2015-309298","volume":"65","author":"KN Phoa","year":"2016","unstructured":"Phoa KN, Pouw RE, Bisschops R, Pech O, Ragunath K, Weusten BLAM, Schumacher B, Rembacken B, Meining A, Messmann H, Schoon EJ, Gossner L, Mannath J, Seldenrijk CA, Visser M, Lerut T, Seewald S, ten Kate FJ, Ell C, Neuhaus H, Bergman JJGHM (2016) Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II). Gut 65:555\u2013562. https:\/\/doi.org\/10.1136\/gutjnl-2015-309298","journal-title":"Gut"},{"key":"9914_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cgh.2009.07.003","volume":"8","author":"RE Pouw","year":"2010","unstructured":"Pouw RE, Wirths K, Eisendrath P, Sondermeijer CM, ten Kate FJ, Fockens P, Devi\u00e8re J, Neuhaus H, Bergman JJ (2010) Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett\u2019s esophagus with early neoplasia. Clin Gastroenterol Hepatol 8:23\u201329. https:\/\/doi.org\/10.1016\/j.cgh.2009.07.003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9914_CR20","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1111\/j.1572-0241.2006.00635.x","volume":"101","author":"FP Peters","year":"2006","unstructured":"Peters FP, Kara MA, Rosmolen WD, ten Kate FJW, Krishnadath KK, van Lanschot JJB, Fockens P, Bergman JJGHM (2006) Stepwise radical endoscopic resection is effective for complete removal of Barrett\u2019s esophagus with early neoplasia: a prospective study. Am J Gastroenterol 101:1449\u20131457. https:\/\/doi.org\/10.1111\/j.1572-0241.2006.00635.x","journal-title":"Am J Gastroenterol"},{"key":"9914_CR21","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/s0016-5107(05)00063-5","volume":"61","author":"FP Peters","year":"2005","unstructured":"Peters FP, Kara MA, Rosmolen WD, Aalders MCG, ten Kate FJW, Bultje BC, Krishnadath KK, Fockens P, van Lanschot JJB, van Deventer SJH, Bergman JJGHM (2005) Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett\u2019s esophagus. Gastrointest Endosc 61:506\u2013514. https:\/\/doi.org\/10.1016\/s0016-5107(05)00063-5","journal-title":"Gastrointest Endosc"},{"key":"9914_CR22","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.ejca.2012.02.064","volume":"48","author":"JL Dikken","year":"2012","unstructured":"Dikken JL, Dassen AE, Lemmens VEP, Putter H, Krijnen P, van der Geest L, Bosscha K, Verheij M, van de Velde CJH, Wouters MWJM (2012) Effect of hospital volume on postoperative mortality and survival after oesophageal and gastric cancer surgery in the Netherlands between 1989 and 2009. Eur J Cancer 48:1004\u20131013. https:\/\/doi.org\/10.1016\/j.ejca.2012.02.064","journal-title":"Eur J Cancer"},{"key":"9914_CR23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ejca.2018.02.025","volume":"94","author":"M van Putten","year":"2018","unstructured":"van Putten M, de Vos-Geelen J, Nieuwenhuijzen GAP, Siersema PD, Lemmens VEPP, Rosman C, van der Sangen MJC, Verhoeven RHA (2018) Long-term survival improvement in oesophageal cancer in the Netherlands. Eur J Cancer 94:138\u2013147. https:\/\/doi.org\/10.1016\/j.ejca.2018.02.025","journal-title":"Eur J Cancer"},{"key":"9914_CR24","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/bjs.7493","volume":"98","author":"L van de Poll-Franse","year":"2011","unstructured":"van de Poll-Franse L, v, Lemmens VEPP, Roukema JA, Coebergh JWW, Nieuwenhuijzen GAP, (2011) Impact of concentration of oesophageal and gastric cardia cancer surgery on long-term population-based survival. Br J Surg 98:956\u2013963. https:\/\/doi.org\/10.1002\/bjs.7493","journal-title":"Br J Surg"},{"key":"9914_CR25","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1245\/s10434-015-5061-7","volume":"23","author":"M Ko\u00ebter","year":"2016","unstructured":"Ko\u00ebter M, Parry K, Verhoeven RHA, Luyer MDP, Ruurda JP, van Hillegersberg R, Lemmens VEPP, Nieuwenhuijzen GAP (2016) Perioperative treatment, not surgical approach, influences overall survival in patients with gastroesophageal junction tumors: a nationwide, population-based study in the Netherlands. Ann Surg Oncol 23:1632\u20131638. https:\/\/doi.org\/10.1245\/s10434-015-5061-7","journal-title":"Ann Surg Oncol"},{"key":"9914_CR26","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/j.ejso.2021.12.447","volume":"48","author":"S Brunner","year":"2022","unstructured":"Brunner S, Schroder W, Frebel A, de Jongh C, Ruurda JP, van Hillegersberg R, Bruns C (2022) The CARDIA trail. Eur J Surg Oncol 48:e29\u2013e43","journal-title":"Eur J Surg Oncol"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-023-09914-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-023-09914-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-023-09914-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T16:09:31Z","timestamp":1685635771000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-023-09914-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["9914"],"URL":"https:\/\/doi.org\/10.1007\/s00464-023-09914-x","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,27]]},"assertion":[{"value":"4 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Irma C. Noordzij, Marije L. Hazen, Grard A.P. Nieuwenhuijzen, Rob H.A. Verhoeven and Erik J. Schoon have no conflicts of interest of financial ties to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}